LRIG1 gene copy number analysis by ddPCR and correlations to clinical factors in breast cancer

Cancer treatment and survivorship statistics, 2016

(2016) Kimberly D. Miller et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival

(2015) B. B. Oven Ustaalioglu et al.   Clinical & Translational Oncology

LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells

(2015) N Yokdang et al.   ONCOGENE

LRIG and cancer prognosis

(2014) David Lindquist et al.   ACTA ONCOLOGICA

Loss of LRIG1 Locus Increases Risk of Early and Late Relapse of Stage I/II Breast Cancer

(2014) P. A. Thompson et al.   CANCER RESEARCH

Breast cancer statistics, 2013

(2013) Carol DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype

(2011) Aoife J. Lowery et al.   BREAST CANCER RESEARCH AND TREATMENT

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION

Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates with Longer Relapse-Free Survival in ER -Positive Breast Cancer

(2011) S. R. Krig et al.   MOLECULAR CANCER RESEARCH

Selective Genomic Copy Number Imbalances and Probability of Recurrence in Early-Stage Breast Cancer

(2011) Patricia A. Thompson et al.   PLoS One

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Suppression of the Negative Regulator LRIG1 Contributes to ErbB2 Overexpression in Breast Cancer

(2008) J. K. Miller et al.   CANCER RESEARCH